The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Update – Notification of Change of Venue

19 Mar 2020 16:30

RNS Number : 8613G
Maven Income and Growth VCT 3 PLC
19 March 2020
 

MAVEN INCOME AND GROWTH VCT 3 PLC

2020 AGM UPDATE - NOTIFICATION OF CHANGE OF VENUE

Maven Income and Growth VCT 3 PLC (the Company) announced its Annual Financial Results for the year to 30 November 2019 on 10 March 2020, including notice that the Annual General Meeting (AGM) would be held in London on Wednesday, 8 April 2020 at 12.00 noon.

In respect of the evolving Coronavirus (COVID-19) situation, which the Board is monitoring closely, the Directors of the Company consider the well-being of its Shareholders and other AGM attendees as a high priority. Based on the latest available advice, the AGM is expected to proceed on 8 April 2020 as planned, however, the Board has resolved that the venue of the AGM should be moved from London to Glasgow.

Accordingly, the Company's 2020 AGM will be held on Wednesday, 8 April 2020 at 12.00 noon at the offices of Maven Capital Partners UK LLP, First Floor, Kintyre House, 205 West George Street, Glasgow G2 2LW.

In further consideration of the current situation, Shareholders should also note that only the formal business set out in the Notice of Annual General Meeting, as included in the Annual Report for the year ended 30 November 2019 published on 10 March 2020, will be considered at the AGM and that there will be no presentation by the Manager. The meeting will be conducted swiftly and the room will be vacated promptly following the close of the meeting. No refreshments will be served.

The Directors are aware that the AGM is a good opportunity for Shareholders to meet the Board and the Manager. However, given the possible health risks arising from travel to, and interaction at, the AGM, Shareholders are actively encouraged to consider whether their attendance at the AGM is necessary. Shareholders wishing to vote on any of the matters of business are urged to do so through completion of a Proxy Form, which can be submitted to the Company. Proxy Forms should be completed and returned in accordance with the instructions thereon and the latest time for the receipt of Proxy Forms is 12.00 noon on Monday, 6 April 2020. Proxy votes can be also be submitted by CREST or on-line using the Registrar's Share Portal Service at www.signalshares.com.

The Board would, therefore, encourage Shareholders not to attend in person and instead submit any questions by e-mail or by letter in advance of the AGM. A summary of responses will be published after the AGM on the Company's website at: www.mavencp.com/migvct3.

Shareholders wishing to submit a question should write to: The Company Secretary, Maven Income and Growth VCT 3 PLC, c/o Maven Capital Partners UK LLP, First Floor, Kintyre House, 205 West George Street, Glasgow G2 2LW or email: CoSec@mavencp.com.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

 

19 March 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOAFLFLRVEIALII
Date   Source Headline
1st Feb 20233:23 pmRNSUnaudited NAV and Proposed Final Dividend
12th Dec 20223:41 pmRNSDirectorate Change
12th Dec 20223:34 pmRNSStatement re Director's Other Quoted Directorships
9th Nov 20223:00 pmRNSResult of General Meeting
4th Nov 20222:35 pmRNSTransaction in Own Shares
31st Oct 20223:54 pmRNSTransaction in Own Shares
21st Oct 20222:45 pmRNSNet Asset Value(s)
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
26th Aug 202210:04 amRNSIssue of Equity
22nd Aug 20229:33 amRNSStatement re Dividend Investment Scheme
29th Jul 202211:25 amRNSHalf-year Report
21st Jul 20224:38 pmRNSTransaction in Own Shares
13th Jul 202211:19 amRNSNet Asset Value and Interim Dividend
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
6th Jun 20222:15 pmRNSIssue of Equity
26th May 20225:02 pmRNSTransaction in Own Shares
26th Apr 202212:34 pmRNSIssue of Supplementary Prospectus
26th Apr 202210:51 amRNSIssue of Equity - Dividend Investment Scheme
21st Apr 20222:39 pmRNSStatement re Dividend Investment Scheme
6th Apr 20224:02 pmRNSNet Asset Value(s)
6th Apr 20221:45 pmRNSResult of AGM
5th Apr 20226:30 pmRNSIssue of Equity
23rd Mar 20225:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20225:05 pmRNSIssue of Equity
21st Mar 20222:59 pmRNSPublication of Suppl.Prospcts
11th Mar 202211:35 amRNSIssue of Equity - Dividend Investment Scheme
10th Mar 202211:30 amRNSIssue of Equity
10th Mar 202211:20 amRNSStatement re Dividend Investment Scheme
7th Mar 20226:32 pmRNSAnnual Financial Report
22nd Feb 20222:27 pmRNSTransaction in Own Shares
18th Feb 20225:48 pmRNSIssue of Equity - Replacement Announcement
7th Feb 20221:53 pmRNSDirector/PDMR Shareholding
7th Feb 20221:52 pmRNSDirector/PDMR Shareholding
7th Feb 20221:50 pmRNSDirector/PDMR Shareholding
7th Feb 20221:48 pmRNSDirector/PDMR Shareholding
7th Feb 20221:47 pmRNSDirector/PDMR Shareholding
7th Feb 20221:46 pmRNSDirector/PDMR Shareholding
7th Feb 202210:50 amRNSIssue of Equity
4th Feb 20229:45 amRNSStatement re NAV and Final Dividend
31st Jan 20224:25 pmRNSStatement re Offer for Subscription
10th Jan 202212:43 pmRNSStatement re Offer for Subscription
5th Jan 202210:35 amRNSDividend Declaration
24th Nov 20214:45 pmRNSTransaction in Own Shares
29th Oct 202112:44 pmRNSNet Asset Value(s)
20th Oct 20214:46 pmRNSResult of General Meeting
20th Sep 20215:21 pmRNSPublication of a Prospectus
20th Sep 20214:57 pmRNSStatement re Change of Registrar
10th Sep 202112:34 pmRNSIssue of Equity
7th Sep 20213:08 pmRNSStatement re Dividend Investment Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.